Table 1 Baseline characteristics of study participants according to vaccination schedule.
Variable | Heterologous | Homologous |
|---|---|---|
N | 14,325 | 14,325 |
Socio-demographic and socio-economic | ||
Mean (SD) age, years | 42.20 (9.60) | 42.21 (9.57) |
Female sex | 8959 (62.5%) | 8959 (62.5%) |
Socio-economic status: first quartile (least deprived) | 2725 (19.02%) | 2745 (19.16%) |
Socio-economic status: second quartile | 4403 (30.74%) | 4363 (30.46%) |
Socio-economic status: third quartile | 2162 (15.09%) | 2145 (14.97%) |
Socio-economic status: fourth quartile (most deprived) | 2260 (15.78%) | 2276 (15.89%) |
Residence in a rural area | 2775 (19.37%) | 2796 (19.52%) |
Medicines use | ||
Analgesics | 654 (4.57%) | 533 (3.72%) |
Sedatives/hypnotics | 1049 (7.32%) | 948 (6.62%) |
Anticoagulants | 201 (1.40%) | 116 (0.81%) |
Antidepressants | 1228 (8.57%) | 1077 (7.52%) |
Antiepileptics | 449 (3.13%) | 353 (2.46%) |
Antipsychotics | 281 (1.96%) | 157 (1.10%) |
Antacids | 618 (4.31%) | 533 (3.72%) |
Systemic corticosteroids | 101 (0.71%) | 82 (0.57%) |
Oral antidiabetics | 187 (1.31%) | 150 (1.05%) |
Insulin | 105 (0.73%) | 73 (0.51%) |
Lipid modifying agents | 453 (3.16%) | 410 (2.86%) |
Alpha blockers | 5 (0.03%) | 2 (0.01%) |
Other antihypertensives | 4 (0.03%) | 1 (0.01%) |
Beta blockers | 202 (1.41%) | 193 (1.35%) |
Calcium channel blockers | 135 (0.94%) | 101 (0.71%) |
Combination antihypertensives | 209 (1.46%) | 176 (1.23%) |
Diuretics | 103 (0.72%) | 108 (0.75%) |
ACE inhibitors/ARBs | 423 (2.95%) | 424 (2.96%) |
Chronic obstructive pulmonary disease/asthma inhalers | 579 (4.04%) | 528 (3.69%) |
Comorbidities | ||
Atrial fibrillation | 23 (0.16%) | 19 (0.13%) |
Osteoarthritis | 513 (3.58%) | 533 (3.72%) |
Asthma | 935 (6.53%) | 910 (6.35%) |
Ischaemic heart disease | 48 (0.34%) | 38 (0.27%) |
Diabetes mellitus | 266 (1.86%) | 209 (1.46%) |
Liver disease | 289 (2.02%) | 278 (1.94%) |
Hypertension | 826 (5.77%) | 814 (5.68%) |
Heart failure | 5 (0.03%) | 2 (0.01%) |
Cerebrovascular disease | 41 (0.29%) | 26 (0.18%) |
Chronic obstructive pulmonary disease | 46 (0.32%) | 37 (0.26%) |
Chronic kidney disease | 44 (0.31%) | 54 (0.38%) |
Cancer (all except non-melanoma skin cancer) | 344 (2.40%) | 325 (2.27%) |
Obesity | 1539 (10.74%) | 1391 (9.71%) |
Valvular disease | 73 (0.51%) | 64 (0.45%) |
Hepatitis B | 20 (0.14%) | 15 (0.10%) |
Hepatitis C | 49 (0.34%) | 34 (0.24%) |
HIV infection | 49 (0.34%) | 47 (0.33%) |
